Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04119037 · ClinicalTrials.gov registry record · NA
Cordotomy in Reducing Pain in Patients With Advanced Cancer
A NA study of Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT04119037: Active NA study of Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04119037 is a NA study of Advanced Malignant Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 27 participants, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04119037, a NA study of Advanced Malignant Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well cordotomy works in reducing pain in patients with cancer that has spread to other places in the body (advanced). Cordotomy is performed on the spinal cord with a needle and guided by computed tomography scans and is designed to help reduce pain. This study is being done to learn if a cordotomy reduces pain in patients with unmanageable cancer pain.
Primary Outcome
Will be measured by the Edmonton Symptom Assessment Scale (ESAS).
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- DRUG Morphine
- PROCEDURE Sham Intervention
- PROCEDURE Cordotomy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What the registry record for NCT04119037 still lists
NCT04119037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Advanced Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT04119037 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04119037 about?
NCT04119037 is a clinical study titled "Cordotomy in Reducing Pain in Patients With Advanced Cancer". This trial studies how well cordotomy works in reducing pain in patients with cancer that has spread to other places in the body (advanced). Cordotomy is performed on the spinal cord with a needle and guided by computed tomography scans and is designed to help reduce pain. This study is being done t...
What is the current status of trial NCT04119037?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2019-09-16. Estimated completion is 2028-12-01.
What conditions does trial NCT04119037 study?
This clinical trial studies the following conditions: Advanced Malignant Neoplasm.
What interventions are being tested in trial NCT04119037?
The interventions under investigation include: Questionnaire Administration (OTHER), Morphine (DRUG), Sham Intervention (PROCEDURE), Cordotomy (PROCEDURE).
Who is sponsoring clinical trial NCT04119037?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04119037 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04119037's enrollment target sits among peer trials
27 17th of 16 the lowest of 16 other Advanced Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
ACTIVE NOT RECRUITING · NA
-
RCT of QPS vs General Information Sheet
ACTIVE NOT RECRUITING · NA
-
Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children
COMPLETED · NA
-
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits
COMPLETED · NA
-
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RECRUITING · Phase 1
-
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI